Old Web
English
Sign In
Acemap
>
authorDetail
>
Xueyan Liao
Xueyan Liao
Merck & Co.
Vaccination
Adverse effect
Placebo
Rotavirus vaccine
Immunology
2
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in Chinese females aged 9 to 26 years: A phase 3, open-label, immunobridging study.
2020
Vaccine
Zhuhang Huang
Jianfeng He
Jiali Su
Zhiqiang Ou
Guixiu Liu
Rong Fu
Qiong Shou
Minghuan Zheng
Alain Luxembourg
Xueyan Liao
Jikai Zhang
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial
2017
Vaccine
Zhaojun Mo
Yi Mo
Mingqiang Li
Junhui Tao
Xu Yang
Jilian Kong
Dingkai Wei
Botao Fu
Xueyan Liao
Jianli Chu
Yuanzheng Qiu
Darcy A. Hille
Micki Nelson
Susan S. Kaplan
Show All
Source
Cite
Save
Citations (19)
1